Transmission of donor Epstein—Barr virus (EBV) in transplanted organs causes lymphoproliferative disease in EBV-seronegative recipients

References

1. Baer R., Bankier A. T., Biggin M. D., Deninger P. L., Farrell P. J., Gibson T. J., Hatfull G., Hudson G. S., Satchwell S. C., Sequin G., Tuffnell P. S., Barrell B. G. 1984; DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207–211
   [Google Scholar]
2. Brooks L. A., Thomas J. A. 1995; The significance of Epstein-Barr virus in the pathogenesis of lymphoid and epithelial neoplasia. Current Diagnostic Pathology 2:163–174
   [Google Scholar]
3. Cen H., Breinig M. C., Atchison R. W., Ho M., McKnight J. L. C. 1991; Epstein-Barr virus transmission via the donor organ in solid organ transplantation: polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3 and IR4. Journal of Virology 65:976–980
   [Google Scholar]
4. Colby B., Shaw J., Elion G., Pagano J. 1980; Effects of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication. Journal of Virology 34:560–568
   [Google Scholar]
5. Falk K., Gratama J. W., Rowe M., Zou J. Z., Khanim F., Young L. S., Oosterveer M. A. P., Ernberg I. 1995; The role of repetitive DNA sequences in the size of Epstein-Barr virus (EBV) nuclear antigens, and the identification of different EBV isolates using RFLP and PCR analysis. Journal of General Virology 76:779–790
   [Google Scholar]
6. Gratama J. W., Oosterveer M. A. P., Zwaan F. E., Lepoutre J., Klein G., Ernberg I. 1988; Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency. Proceedings of the National Academy of Sciences, USA 85:8693–8696
   [Google Scholar]
7. Henle G., Henle W. 1966; Immunofluorescence in cells derived from Burkitt’s lymphoma. Journal of Bacteriology 91:1248–1256
   [Google Scholar]
8. Ho M., Jaffe R., Miller G., Breinig M. K., Dummer J. S., Makowka L., Atchison R. W., Karrer F., Nalesnik M. A., Starzl T. E. 1988; The frequency of Epstein-Barr virus infection and associated lymphoproliferative disease after transplantation and its manifestations in children. Transplantation 45:719–727
   [Google Scholar]
9. Rooney C. M., Smith C. A., Ng C. Y. C. 1995; Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation. Lancet 345:9–12
   [Google Scholar]
10. Saiki R. K., Scharf S., Faloona F., Mullis K. B., Horn G. T., Erlich H. A. 1985; Enzymatic amplification of β;-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anaemia. Science 230:1350–1354
    [Google Scholar]
11. Sambrook J., Fritsch E. F., Maniatis T. 1989; Molecular Cloning: A Laboratory Manual. 2nd edn New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
12. Sixbey J. W., Shirley P., Chesney P. J., Buntin D. M., Resnick L. 1989; Detection of a second widespread strain of Epstein-Barr virus. Lancet ii:761–765
    [Google Scholar]
13. Thomas J. A., Crawford D. H., Burke M. 1995; Clinico-pathological implications of Epstein-Barr virus related B cell lymphoma in immunocompromised patients. Journal of Clinical Pathology 48:287–290
    [Google Scholar]
14. Van Gelder T., Kroes L. C. M., Mulder A., Gratama J. W., Weimer W. 1994; A living-related kidney donor as the source of a nearly fatal primary Epstein-Barr virus infection following transplantation. Transplantation 58:852–855
    [Google Scholar]